Wyatt Technology will Host 21st Annual International Light Scattering Colloquium
News May 28, 2010
Wyatt Technology has announce that it will host its 21st Annual International Light Scattering Colloquium (ILSC) October 18-19, 2010 at the exclusive Four Seasons Biltmore Resort in Santa Barbara, California.
The event will welcome an array of high-profile Wyatt Technology light scattering customers including Nobel Prize winner, Professor Roger Yonchien Tsien. To complement the 21st annual ILSC, Wyatt Technology will also be hosting an Eclipse Field Flow Fractionation (FFF)-MALS Focus Meeting on October 20 2010.
Over the past 21 years, the ILSC has secured its status as the pre-eminent meeting for light scattering (LS) for both static and dynamic LS users.
Introduced by Wyatt Technology to provide its new and existing customers from around the world with the opportunity to gather to discuss their light scattering experiences, the colloquium has grown to become a world-leading event for all industry professionals. This year's colloquium will showcase Wyatt's new Möbiu? mobility instrument, following its successful launch at Pittcon 2010 where the instrument was given an honorable mention in the Pittcon Editor's Choice Award.
The Möbiu? is the only laser-based instrument that achieves reproducible measurements of traditionally very challenging protein samples, including antibody formulations, bovine serum albumin and lysozyme.
Wyatt's Dynamic Light Scattering (DLS) solutions from the DynaPro product line will also be featured, in addition to its own classical light scattering (DAWN and miniDAWN), viscometer (ViscoStar), and Eclipse AFFF products.
The delegates at the colloquium will have the opportunity to listen to a panel of expert speakers presenting a range of applications all utilizing Wyatt Technology's instruments. There are also several Poster Discussion sessions planned to stimulate different application conversations throughout the two days, with attendees presenting their own data and discussing method development.
Speaking at this year's ILSC will be Professor Krzysztof Matyjaszewski from Carnegie Mellon University, Dr. Michael McCarthy from MedImmune Incorporated, Dr. Richard Vandlen from Genentech Inc and Dr. Robert Rambo of Lawrence Berkeley National Laboratories. Professor Roger Tsien of the University of California, who will also be speaking at the event, was awarded the 2008 Nobel Prize in chemistry for his contribution to the discovery and development of the green fluorescent protein (GFP). He will deliver a lecture on "How Light Scattering Helps Us Characterize Molecular Spies" at the ILSC.
The MALS Focus Meeting on the third day of the colloquium will be dedicated to the exchange of experience among users of the Eclipse FFF system. The application focus of the meeting will be proteins, biopolymers and liposome/virus particles and it will take the format of a round-table discussion, structured along different topics. For each session there will be a talk given by an expert in the corresponding topic as an introduction to the general discussion.
As well as listening to industry experts, participants will also be provided with an opportunity to deliver short presentations of their own results and present problems or questions to the experts for general discussion.
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE